Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00401-014-1352-5.

Title:
Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas | Acta Neuropathologica
Description:
Anti-angiogenic therapy in glioblastoma (GBM) has unfortunately not led to the anticipated improvement in patient prognosis. We here describe how human GBM adapts to bevacizumab treatment at the metabolic level. By performing 13C6-glucose metabolic flux analysis, we show for the first time that the tumors undergo metabolic re-programming toward anaerobic metabolism, thereby uncoupling glycolysis from oxidative phosphorylation. Following treatment, an increased influx of 13C6-glucose was observed into the tumors, concomitant to increased lactate levels and a reduction of metabolites associated with the tricarboxylic acid cycle. This was confirmed by increased expression of glycolytic enzymes including pyruvate dehydrogenase kinase in the treated tumors. Interestingly, l-glutamine levels were also reduced. These results were further confirmed by the assessment of in vivo metabolic data obtained by magnetic resonance spectroscopy and positron emission tomography. Moreover, bevacizumab led to a depletion in glutathione levels indicating that the treatment caused oxidative stress in the tumors. Confirming the metabolic flux results, immunohistochemical analysis showed an up-regulation of lactate dehydrogenase in the bevacizumab-treated tumor core as well as in single tumor cells infiltrating the brain, which may explain the increased invasion observed after bevacizumab treatment. These observations were further validated in a panel of eight human GBM patients in which paired biopsy samples were obtained before and after bevacizumab treatment. Importantly, we show that the GBM adaptation to bevacizumab therapy is not mediated by clonal selection mechanisms, but represents an adaptive response to therapy.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't see how the site brings in money.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

tumor, treatment, pubmed, bevacizumab, tumors, article, google, scholar, cas, fig, cells, increased, analysis, cell, central, levels, metabolic, cancer, glioblastoma, expression, brain, lactate, min, tissue, glucose, therapy, human, observed, panel, gbms, data, reduction, animals, antiangiogenic, gbm, flux, treated, reduced, results, invasion, supplementary, control, glycolysis, metabolites, patients, growth, metabolism, bevacizumabtreated, samples, increase,

Topics {✒️}

egfp nod/scid mice microscopic high-power fields anna golebiewska article download pdf agar pre-coated flasks tyrosine kinase inhibitor heidi espedal olivier keunen author information authors pro-angiogenic myelogenic cells ct x-ray images pro-invasive programs characterized de groot jf original author supply tca-derived precursors anti-von willebrand factor 18f-fmiso pet images resist anti-angiogenic therapy 18f-fmiso pet imaging performed 13c6-glucose injections cancer research uk anti-angiogenic treatment selects egfp-expressing mice cell membrane markers rt-qpcr analysis shows view study tumor-host interactions anti-vegf antibody treatment eyal gottlieb hu yl counting nestin-positive cells real-time quantitative pcr mrs-identified lactate concentration grade iii meningiomas author correspondence metabolic flux analyses matrix size 250 × 250 × 250 μm niclou & rolf bjerkvig anti-angiogenic treatment leads keunen equally contributed morten lund-johansen full access biotinylated secondary antibody hplc grade purity lc–ms ion counts anti-vegf treatment leads plate kh subclinical tumour response anti-β-actin 1 determine nadp+/nadph ratios

Questions {❓}

  • Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas
         description:Anti-angiogenic therapy in glioblastoma (GBM) has unfortunately not led to the anticipated improvement in patient prognosis. We here describe how human GBM adapts to bevacizumab treatment at the metabolic level. By performing 13C6-glucose metabolic flux analysis, we show for the first time that the tumors undergo metabolic re-programming toward anaerobic metabolism, thereby uncoupling glycolysis from oxidative phosphorylation. Following treatment, an increased influx of 13C6-glucose was observed into the tumors, concomitant to increased lactate levels and a reduction of metabolites associated with the tricarboxylic acid cycle. This was confirmed by increased expression of glycolytic enzymes including pyruvate dehydrogenase kinase in the treated tumors. Interestingly, l-glutamine levels were also reduced. These results were further confirmed by the assessment of in vivo metabolic data obtained by magnetic resonance spectroscopy and positron emission tomography. Moreover, bevacizumab led to a depletion in glutathione levels indicating that the treatment caused oxidative stress in the tumors. Confirming the metabolic flux results, immunohistochemical analysis showed an up-regulation of lactate dehydrogenase in the bevacizumab-treated tumor core as well as in single tumor cells infiltrating the brain, which may explain the increased invasion observed after bevacizumab treatment. These observations were further validated in a panel of eight human GBM patients in which paired biopsy samples were obtained before and after bevacizumab treatment. Importantly, we show that the GBM adaptation to bevacizumab therapy is not mediated by clonal selection mechanisms, but represents an adaptive response to therapy.
         datePublished:2014-10-17T00:00:00Z
         dateModified:2014-10-17T00:00:00Z
         pageStart:115
         pageEnd:131
         sameAs:https://doi.org/10.1007/s00401-014-1352-5
         keywords:
            Glioblastoma
            Bevacizumab
            Metabolism
            Adaptation
            Pathology
            Neurosciences
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-014-1352-5/MediaObjects/401_2014_1352_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-014-1352-5/MediaObjects/401_2014_1352_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-014-1352-5/MediaObjects/401_2014_1352_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-014-1352-5/MediaObjects/401_2014_1352_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-014-1352-5/MediaObjects/401_2014_1352_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-014-1352-5/MediaObjects/401_2014_1352_Fig6_HTML.gif
         isPartOf:
            name:Acta Neuropathologica
            issn:
               1432-0533
               0001-6322
            volumeNumber:129
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Fred Fack
               affiliation:
                     name:Centre de Recherche Public de la Santé
                     address:
                        name:NorLux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé, Strassen, Luxembourg
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Heidi Espedal
               affiliation:
                     name:University of Bergen
                     address:
                        name:NorLux Neuro-Oncology, Department of Biomedicine, University of Bergen, Bergen, Norway
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Olivier Keunen
               affiliation:
                     name:Centre de Recherche Public de la Santé
                     address:
                        name:NorLux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé, Strassen, Luxembourg
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Anna Golebiewska
               affiliation:
                     name:Centre de Recherche Public de la Santé
                     address:
                        name:NorLux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé, Strassen, Luxembourg
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Nina Obad
               affiliation:
                     name:University of Bergen
                     address:
                        name:NorLux Neuro-Oncology, Department of Biomedicine, University of Bergen, Bergen, Norway
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Patrick N. Harter
               affiliation:
                     name:Goethe University, Hospital Frankfurt
                     address:
                        name:Edinger Institute, Institute of Neurology, Goethe University, Hospital Frankfurt, Frankfurt am Main, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Michel Mittelbronn
               affiliation:
                     name:Goethe University, Hospital Frankfurt
                     address:
                        name:Edinger Institute, Institute of Neurology, Goethe University, Hospital Frankfurt, Frankfurt am Main, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Oliver Bähr
               affiliation:
                     name:Goethe University, Hospital Frankfurt
                     address:
                        name:Dr. Senckenberg Institute of Neurooncology, Goethe University, Hospital Frankfurt, Frankfurt am Main, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Astrid Weyerbrock
               affiliation:
                     name:University Hospital Freiburg
                     address:
                        name:Department of Neurosurgery, University Hospital Freiburg, Freiburg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Linda Stuhr
               affiliation:
                     name:University of Bergen
                     address:
                        name:Matrix Biology Group, Department of Biomedicine, University of Bergen, Bergen, Norway
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hrvoje Miletic
               affiliation:
                     name:University of Bergen
                     address:
                        name:NorLux Neuro-Oncology, Department of Biomedicine, University of Bergen, Bergen, Norway
                        type:PostalAddress
                     type:Organization
                     name:Haukeland University Hospital, The Gade Institute
                     address:
                        name:Department of Pathology, Haukeland University Hospital, The Gade Institute, Bergen, Norway
                        type:PostalAddress
                     type:Organization
                     name:University of Bergen
                     address:
                        name:KG Jebsen Brain Tumour Research Center, University of Bergen, Bergen, Norway
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Per Ø. Sakariassen
               affiliation:
                     name:University of Bergen
                     address:
                        name:NorLux Neuro-Oncology, Department of Biomedicine, University of Bergen, Bergen, Norway
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Daniel Stieber
               affiliation:
                     name:Centre de Recherche Public de la Santé
                     address:
                        name:NorLux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé, Strassen, Luxembourg
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Cecilie B. Rygh
               affiliation:
                     name:Molecular Imaging Center, University of Bergen
                     address:
                        name:Department of Biomedicine, Molecular Imaging Center, University of Bergen, Bergen, Norway
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Morten Lund-Johansen
               affiliation:
                     name:Haukeland University Hospital
                     address:
                        name:Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway
                        type:PostalAddress
                     type:Organization
                     name:University of Bergen
                     address:
                        name:KG Jebsen Brain Tumour Research Center, University of Bergen, Bergen, Norway
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Liang Zheng
               affiliation:
                     name:Beatson Institute
                     address:
                        name:Cancer Research UK, Beatson Institute, Glasgow, Scotland, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Eyal Gottlieb
               affiliation:
                     name:Beatson Institute
                     address:
                        name:Cancer Research UK, Beatson Institute, Glasgow, Scotland, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Simone P. Niclou
               affiliation:
                     name:Centre de Recherche Public de la Santé
                     address:
                        name:NorLux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé, Strassen, Luxembourg
                        type:PostalAddress
                     type:Organization
                     name:University of Bergen
                     address:
                        name:KG Jebsen Brain Tumour Research Center, University of Bergen, Bergen, Norway
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Rolf Bjerkvig
               affiliation:
                     name:Centre de Recherche Public de la Santé
                     address:
                        name:NorLux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé, Strassen, Luxembourg
                        type:PostalAddress
                     type:Organization
                     name:University of Bergen
                     address:
                        name:NorLux Neuro-Oncology, Department of Biomedicine, University of Bergen, Bergen, Norway
                        type:PostalAddress
                     type:Organization
                     name:University of Bergen
                     address:
                        name:KG Jebsen Brain Tumour Research Center, University of Bergen, Bergen, Norway
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas
      description:Anti-angiogenic therapy in glioblastoma (GBM) has unfortunately not led to the anticipated improvement in patient prognosis. We here describe how human GBM adapts to bevacizumab treatment at the metabolic level. By performing 13C6-glucose metabolic flux analysis, we show for the first time that the tumors undergo metabolic re-programming toward anaerobic metabolism, thereby uncoupling glycolysis from oxidative phosphorylation. Following treatment, an increased influx of 13C6-glucose was observed into the tumors, concomitant to increased lactate levels and a reduction of metabolites associated with the tricarboxylic acid cycle. This was confirmed by increased expression of glycolytic enzymes including pyruvate dehydrogenase kinase in the treated tumors. Interestingly, l-glutamine levels were also reduced. These results were further confirmed by the assessment of in vivo metabolic data obtained by magnetic resonance spectroscopy and positron emission tomography. Moreover, bevacizumab led to a depletion in glutathione levels indicating that the treatment caused oxidative stress in the tumors. Confirming the metabolic flux results, immunohistochemical analysis showed an up-regulation of lactate dehydrogenase in the bevacizumab-treated tumor core as well as in single tumor cells infiltrating the brain, which may explain the increased invasion observed after bevacizumab treatment. These observations were further validated in a panel of eight human GBM patients in which paired biopsy samples were obtained before and after bevacizumab treatment. Importantly, we show that the GBM adaptation to bevacizumab therapy is not mediated by clonal selection mechanisms, but represents an adaptive response to therapy.
      datePublished:2014-10-17T00:00:00Z
      dateModified:2014-10-17T00:00:00Z
      pageStart:115
      pageEnd:131
      sameAs:https://doi.org/10.1007/s00401-014-1352-5
      keywords:
         Glioblastoma
         Bevacizumab
         Metabolism
         Adaptation
         Pathology
         Neurosciences
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-014-1352-5/MediaObjects/401_2014_1352_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-014-1352-5/MediaObjects/401_2014_1352_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-014-1352-5/MediaObjects/401_2014_1352_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-014-1352-5/MediaObjects/401_2014_1352_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-014-1352-5/MediaObjects/401_2014_1352_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-014-1352-5/MediaObjects/401_2014_1352_Fig6_HTML.gif
      isPartOf:
         name:Acta Neuropathologica
         issn:
            1432-0533
            0001-6322
         volumeNumber:129
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Fred Fack
            affiliation:
                  name:Centre de Recherche Public de la Santé
                  address:
                     name:NorLux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé, Strassen, Luxembourg
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Heidi Espedal
            affiliation:
                  name:University of Bergen
                  address:
                     name:NorLux Neuro-Oncology, Department of Biomedicine, University of Bergen, Bergen, Norway
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Olivier Keunen
            affiliation:
                  name:Centre de Recherche Public de la Santé
                  address:
                     name:NorLux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé, Strassen, Luxembourg
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Anna Golebiewska
            affiliation:
                  name:Centre de Recherche Public de la Santé
                  address:
                     name:NorLux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé, Strassen, Luxembourg
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Nina Obad
            affiliation:
                  name:University of Bergen
                  address:
                     name:NorLux Neuro-Oncology, Department of Biomedicine, University of Bergen, Bergen, Norway
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Patrick N. Harter
            affiliation:
                  name:Goethe University, Hospital Frankfurt
                  address:
                     name:Edinger Institute, Institute of Neurology, Goethe University, Hospital Frankfurt, Frankfurt am Main, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Michel Mittelbronn
            affiliation:
                  name:Goethe University, Hospital Frankfurt
                  address:
                     name:Edinger Institute, Institute of Neurology, Goethe University, Hospital Frankfurt, Frankfurt am Main, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Oliver Bähr
            affiliation:
                  name:Goethe University, Hospital Frankfurt
                  address:
                     name:Dr. Senckenberg Institute of Neurooncology, Goethe University, Hospital Frankfurt, Frankfurt am Main, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Astrid Weyerbrock
            affiliation:
                  name:University Hospital Freiburg
                  address:
                     name:Department of Neurosurgery, University Hospital Freiburg, Freiburg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Linda Stuhr
            affiliation:
                  name:University of Bergen
                  address:
                     name:Matrix Biology Group, Department of Biomedicine, University of Bergen, Bergen, Norway
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hrvoje Miletic
            affiliation:
                  name:University of Bergen
                  address:
                     name:NorLux Neuro-Oncology, Department of Biomedicine, University of Bergen, Bergen, Norway
                     type:PostalAddress
                  type:Organization
                  name:Haukeland University Hospital, The Gade Institute
                  address:
                     name:Department of Pathology, Haukeland University Hospital, The Gade Institute, Bergen, Norway
                     type:PostalAddress
                  type:Organization
                  name:University of Bergen
                  address:
                     name:KG Jebsen Brain Tumour Research Center, University of Bergen, Bergen, Norway
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Per Ø. Sakariassen
            affiliation:
                  name:University of Bergen
                  address:
                     name:NorLux Neuro-Oncology, Department of Biomedicine, University of Bergen, Bergen, Norway
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Daniel Stieber
            affiliation:
                  name:Centre de Recherche Public de la Santé
                  address:
                     name:NorLux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé, Strassen, Luxembourg
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Cecilie B. Rygh
            affiliation:
                  name:Molecular Imaging Center, University of Bergen
                  address:
                     name:Department of Biomedicine, Molecular Imaging Center, University of Bergen, Bergen, Norway
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Morten Lund-Johansen
            affiliation:
                  name:Haukeland University Hospital
                  address:
                     name:Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway
                     type:PostalAddress
                  type:Organization
                  name:University of Bergen
                  address:
                     name:KG Jebsen Brain Tumour Research Center, University of Bergen, Bergen, Norway
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Liang Zheng
            affiliation:
                  name:Beatson Institute
                  address:
                     name:Cancer Research UK, Beatson Institute, Glasgow, Scotland, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Eyal Gottlieb
            affiliation:
                  name:Beatson Institute
                  address:
                     name:Cancer Research UK, Beatson Institute, Glasgow, Scotland, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Simone P. Niclou
            affiliation:
                  name:Centre de Recherche Public de la Santé
                  address:
                     name:NorLux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé, Strassen, Luxembourg
                     type:PostalAddress
                  type:Organization
                  name:University of Bergen
                  address:
                     name:KG Jebsen Brain Tumour Research Center, University of Bergen, Bergen, Norway
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Rolf Bjerkvig
            affiliation:
                  name:Centre de Recherche Public de la Santé
                  address:
                     name:NorLux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé, Strassen, Luxembourg
                     type:PostalAddress
                  type:Organization
                  name:University of Bergen
                  address:
                     name:NorLux Neuro-Oncology, Department of Biomedicine, University of Bergen, Bergen, Norway
                     type:PostalAddress
                  type:Organization
                  name:University of Bergen
                  address:
                     name:KG Jebsen Brain Tumour Research Center, University of Bergen, Bergen, Norway
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Acta Neuropathologica
      issn:
         1432-0533
         0001-6322
      volumeNumber:129
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Centre de Recherche Public de la Santé
      address:
         name:NorLux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé, Strassen, Luxembourg
         type:PostalAddress
      name:University of Bergen
      address:
         name:NorLux Neuro-Oncology, Department of Biomedicine, University of Bergen, Bergen, Norway
         type:PostalAddress
      name:Centre de Recherche Public de la Santé
      address:
         name:NorLux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé, Strassen, Luxembourg
         type:PostalAddress
      name:Centre de Recherche Public de la Santé
      address:
         name:NorLux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé, Strassen, Luxembourg
         type:PostalAddress
      name:University of Bergen
      address:
         name:NorLux Neuro-Oncology, Department of Biomedicine, University of Bergen, Bergen, Norway
         type:PostalAddress
      name:Goethe University, Hospital Frankfurt
      address:
         name:Edinger Institute, Institute of Neurology, Goethe University, Hospital Frankfurt, Frankfurt am Main, Germany
         type:PostalAddress
      name:Goethe University, Hospital Frankfurt
      address:
         name:Edinger Institute, Institute of Neurology, Goethe University, Hospital Frankfurt, Frankfurt am Main, Germany
         type:PostalAddress
      name:Goethe University, Hospital Frankfurt
      address:
         name:Dr. Senckenberg Institute of Neurooncology, Goethe University, Hospital Frankfurt, Frankfurt am Main, Germany
         type:PostalAddress
      name:University Hospital Freiburg
      address:
         name:Department of Neurosurgery, University Hospital Freiburg, Freiburg, Germany
         type:PostalAddress
      name:University of Bergen
      address:
         name:Matrix Biology Group, Department of Biomedicine, University of Bergen, Bergen, Norway
         type:PostalAddress
      name:University of Bergen
      address:
         name:NorLux Neuro-Oncology, Department of Biomedicine, University of Bergen, Bergen, Norway
         type:PostalAddress
      name:Haukeland University Hospital, The Gade Institute
      address:
         name:Department of Pathology, Haukeland University Hospital, The Gade Institute, Bergen, Norway
         type:PostalAddress
      name:University of Bergen
      address:
         name:KG Jebsen Brain Tumour Research Center, University of Bergen, Bergen, Norway
         type:PostalAddress
      name:University of Bergen
      address:
         name:NorLux Neuro-Oncology, Department of Biomedicine, University of Bergen, Bergen, Norway
         type:PostalAddress
      name:Centre de Recherche Public de la Santé
      address:
         name:NorLux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé, Strassen, Luxembourg
         type:PostalAddress
      name:Molecular Imaging Center, University of Bergen
      address:
         name:Department of Biomedicine, Molecular Imaging Center, University of Bergen, Bergen, Norway
         type:PostalAddress
      name:Haukeland University Hospital
      address:
         name:Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway
         type:PostalAddress
      name:University of Bergen
      address:
         name:KG Jebsen Brain Tumour Research Center, University of Bergen, Bergen, Norway
         type:PostalAddress
      name:Beatson Institute
      address:
         name:Cancer Research UK, Beatson Institute, Glasgow, Scotland, UK
         type:PostalAddress
      name:Beatson Institute
      address:
         name:Cancer Research UK, Beatson Institute, Glasgow, Scotland, UK
         type:PostalAddress
      name:Centre de Recherche Public de la Santé
      address:
         name:NorLux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé, Strassen, Luxembourg
         type:PostalAddress
      name:University of Bergen
      address:
         name:KG Jebsen Brain Tumour Research Center, University of Bergen, Bergen, Norway
         type:PostalAddress
      name:Centre de Recherche Public de la Santé
      address:
         name:NorLux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé, Strassen, Luxembourg
         type:PostalAddress
      name:University of Bergen
      address:
         name:NorLux Neuro-Oncology, Department of Biomedicine, University of Bergen, Bergen, Norway
         type:PostalAddress
      name:University of Bergen
      address:
         name:KG Jebsen Brain Tumour Research Center, University of Bergen, Bergen, Norway
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Fred Fack
      affiliation:
            name:Centre de Recherche Public de la Santé
            address:
               name:NorLux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé, Strassen, Luxembourg
               type:PostalAddress
            type:Organization
      name:Heidi Espedal
      affiliation:
            name:University of Bergen
            address:
               name:NorLux Neuro-Oncology, Department of Biomedicine, University of Bergen, Bergen, Norway
               type:PostalAddress
            type:Organization
      name:Olivier Keunen
      affiliation:
            name:Centre de Recherche Public de la Santé
            address:
               name:NorLux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé, Strassen, Luxembourg
               type:PostalAddress
            type:Organization
      name:Anna Golebiewska
      affiliation:
            name:Centre de Recherche Public de la Santé
            address:
               name:NorLux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé, Strassen, Luxembourg
               type:PostalAddress
            type:Organization
      name:Nina Obad
      affiliation:
            name:University of Bergen
            address:
               name:NorLux Neuro-Oncology, Department of Biomedicine, University of Bergen, Bergen, Norway
               type:PostalAddress
            type:Organization
      name:Patrick N. Harter
      affiliation:
            name:Goethe University, Hospital Frankfurt
            address:
               name:Edinger Institute, Institute of Neurology, Goethe University, Hospital Frankfurt, Frankfurt am Main, Germany
               type:PostalAddress
            type:Organization
      name:Michel Mittelbronn
      affiliation:
            name:Goethe University, Hospital Frankfurt
            address:
               name:Edinger Institute, Institute of Neurology, Goethe University, Hospital Frankfurt, Frankfurt am Main, Germany
               type:PostalAddress
            type:Organization
      name:Oliver Bähr
      affiliation:
            name:Goethe University, Hospital Frankfurt
            address:
               name:Dr. Senckenberg Institute of Neurooncology, Goethe University, Hospital Frankfurt, Frankfurt am Main, Germany
               type:PostalAddress
            type:Organization
      name:Astrid Weyerbrock
      affiliation:
            name:University Hospital Freiburg
            address:
               name:Department of Neurosurgery, University Hospital Freiburg, Freiburg, Germany
               type:PostalAddress
            type:Organization
      name:Linda Stuhr
      affiliation:
            name:University of Bergen
            address:
               name:Matrix Biology Group, Department of Biomedicine, University of Bergen, Bergen, Norway
               type:PostalAddress
            type:Organization
      name:Hrvoje Miletic
      affiliation:
            name:University of Bergen
            address:
               name:NorLux Neuro-Oncology, Department of Biomedicine, University of Bergen, Bergen, Norway
               type:PostalAddress
            type:Organization
            name:Haukeland University Hospital, The Gade Institute
            address:
               name:Department of Pathology, Haukeland University Hospital, The Gade Institute, Bergen, Norway
               type:PostalAddress
            type:Organization
            name:University of Bergen
            address:
               name:KG Jebsen Brain Tumour Research Center, University of Bergen, Bergen, Norway
               type:PostalAddress
            type:Organization
      name:Per Ø. Sakariassen
      affiliation:
            name:University of Bergen
            address:
               name:NorLux Neuro-Oncology, Department of Biomedicine, University of Bergen, Bergen, Norway
               type:PostalAddress
            type:Organization
      name:Daniel Stieber
      affiliation:
            name:Centre de Recherche Public de la Santé
            address:
               name:NorLux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé, Strassen, Luxembourg
               type:PostalAddress
            type:Organization
      name:Cecilie B. Rygh
      affiliation:
            name:Molecular Imaging Center, University of Bergen
            address:
               name:Department of Biomedicine, Molecular Imaging Center, University of Bergen, Bergen, Norway
               type:PostalAddress
            type:Organization
      name:Morten Lund-Johansen
      affiliation:
            name:Haukeland University Hospital
            address:
               name:Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway
               type:PostalAddress
            type:Organization
            name:University of Bergen
            address:
               name:KG Jebsen Brain Tumour Research Center, University of Bergen, Bergen, Norway
               type:PostalAddress
            type:Organization
      name:Liang Zheng
      affiliation:
            name:Beatson Institute
            address:
               name:Cancer Research UK, Beatson Institute, Glasgow, Scotland, UK
               type:PostalAddress
            type:Organization
      name:Eyal Gottlieb
      affiliation:
            name:Beatson Institute
            address:
               name:Cancer Research UK, Beatson Institute, Glasgow, Scotland, UK
               type:PostalAddress
            type:Organization
      name:Simone P. Niclou
      affiliation:
            name:Centre de Recherche Public de la Santé
            address:
               name:NorLux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé, Strassen, Luxembourg
               type:PostalAddress
            type:Organization
            name:University of Bergen
            address:
               name:KG Jebsen Brain Tumour Research Center, University of Bergen, Bergen, Norway
               type:PostalAddress
            type:Organization
      name:Rolf Bjerkvig
      affiliation:
            name:Centre de Recherche Public de la Santé
            address:
               name:NorLux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé, Strassen, Luxembourg
               type:PostalAddress
            type:Organization
            name:University of Bergen
            address:
               name:NorLux Neuro-Oncology, Department of Biomedicine, University of Bergen, Bergen, Norway
               type:PostalAddress
            type:Organization
            name:University of Bergen
            address:
               name:KG Jebsen Brain Tumour Research Center, University of Bergen, Bergen, Norway
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:NorLux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé, Strassen, Luxembourg
      name:NorLux Neuro-Oncology, Department of Biomedicine, University of Bergen, Bergen, Norway
      name:NorLux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé, Strassen, Luxembourg
      name:NorLux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé, Strassen, Luxembourg
      name:NorLux Neuro-Oncology, Department of Biomedicine, University of Bergen, Bergen, Norway
      name:Edinger Institute, Institute of Neurology, Goethe University, Hospital Frankfurt, Frankfurt am Main, Germany
      name:Edinger Institute, Institute of Neurology, Goethe University, Hospital Frankfurt, Frankfurt am Main, Germany
      name:Dr. Senckenberg Institute of Neurooncology, Goethe University, Hospital Frankfurt, Frankfurt am Main, Germany
      name:Department of Neurosurgery, University Hospital Freiburg, Freiburg, Germany
      name:Matrix Biology Group, Department of Biomedicine, University of Bergen, Bergen, Norway
      name:NorLux Neuro-Oncology, Department of Biomedicine, University of Bergen, Bergen, Norway
      name:Department of Pathology, Haukeland University Hospital, The Gade Institute, Bergen, Norway
      name:KG Jebsen Brain Tumour Research Center, University of Bergen, Bergen, Norway
      name:NorLux Neuro-Oncology, Department of Biomedicine, University of Bergen, Bergen, Norway
      name:NorLux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé, Strassen, Luxembourg
      name:Department of Biomedicine, Molecular Imaging Center, University of Bergen, Bergen, Norway
      name:Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway
      name:KG Jebsen Brain Tumour Research Center, University of Bergen, Bergen, Norway
      name:Cancer Research UK, Beatson Institute, Glasgow, Scotland, UK
      name:Cancer Research UK, Beatson Institute, Glasgow, Scotland, UK
      name:NorLux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé, Strassen, Luxembourg
      name:KG Jebsen Brain Tumour Research Center, University of Bergen, Bergen, Norway
      name:NorLux Neuro-Oncology Laboratory, Department of Oncology, Centre de Recherche Public de la Santé, Strassen, Luxembourg
      name:NorLux Neuro-Oncology, Department of Biomedicine, University of Bergen, Bergen, Norway
      name:KG Jebsen Brain Tumour Research Center, University of Bergen, Bergen, Norway

External Links {🔗}(319)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.74s.